Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp)
- 27 October 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 113 (7), 787-801
- https://doi.org/10.1007/s00702-005-0367-4
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophreniaMolecular Psychiatry, 2002
- Effect of P‐glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphineBritish Journal of Clinical Pharmacology, 2000
- Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrierSynapse, 2000
- P-glycoprotein, a guardian of the brainPublished by Cambridge University Press (CUP) ,1998
- Blood–brain barrier methodology and biologyPublished by Cambridge University Press (CUP) ,1998
- AmisulprideCNS Drugs, 1996
- Cellular localization of P-glycoprotein in brain versus gonadal capillaries.Journal of Histochemistry & Cytochemistry, 1996
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.JCI Insight, 1996
- Co-operative, competitive and non-competitive interactions between modulators of P-glycoproteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993